TB-500 Research Guide

Last updated: March 2026

Thymosin Beta-4 โ€ข Recovery & Healing Peptide

๐Ÿ“‘ Table of Contents

โš ๏ธ Research Purposes Only: TB-500 is sold as a research chemical and is not approved by the FDA for human use. This guide is for educational purposes. Consult a medical professional before using any peptides.

What is TB-500?

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein found in high concentrations in blood platelets, wound fluid, and other tissues. The synthetic version consists of 43 amino acids and is designed to mimic the regenerative properties of the naturally occurring protein.

TB-500 was originally developed for veterinary use, particularly in racehorses, where it showed remarkable healing properties for injured tendons and ligaments. The peptide promotes cell migration, angiogenesis (formation of new blood vessels), and tissue repair.

Areas of Research

What Does the Research Say?

TB-500 research spans both veterinary and laboratory settings, with most human evidence being anecdotal. The peptide has shown promising results in animal models across multiple areas of health and recovery.

Animal Studies (Extensive)

Studies in horses, rats, and mice have demonstrated accelerated healing of soft tissue injuries, improved cardiac function following heart attacks, and enhanced recovery from various traumatic injuries. The peptide appears to work by promoting cell migration and reducing inflammation.

Human Studies (Limited)

Direct human clinical trials are limited, though TB-500's parent compound (Thymosin Beta-4) has been studied in humans for wound healing and cardiac conditions. Most human TB-500 evidence comes from veterinary medicine and anecdotal reports from biohackers and athletes.

Key Research Areas

Dosing Protocols

TB-500 dosing protocols are based primarily on veterinary use and anecdotal reports. The peptide is typically used in cycles due to its longer half-life compared to other peptides.

Phase Dose Frequency Duration
Loading Phase 2-2.5mg 2x per week 4-6 weeks
Maintenance 2mg Once weekly 4-8 weeks
Injury Protocol 2.5mg 2x per week Until healed

Administration Methods

How to Reconstitute TB-500

TB-500 commonly comes in 2mg or 5mg vials as a lyophilized powder. The reconstitution process is straightforward but requires sterile technique.

Standard Reconstitution

2mg vial:

5mg vial:

๐Ÿงฎ Calculate Your Exact Dose

Use our free calculator to determine your concentration and injection volume.

Open Calculator โ†’

Storage Guidelines

Form Storage Shelf Life
Lyophilized (powder) Room temp or refrigerated 2+ years
Reconstituted Refrigerated (36-46ยฐF) 4-6 weeks
Reconstituted Frozen 6+ months

Storage Tips: Keep away from direct light and heat. Don't shake reconstituted vials vigorously. Use bacteriostatic water for longer shelf life. Some users pre-load syringes and freeze individual doses.

Common Stacks

๐Ÿบ "Wolverine Stack" (Most Popular)

TB-500 + BPC-157 โ€” The gold standard combination for injury recovery

Hair Growth Stack

TB-500 + GHK-Cu โ€” For hair regrowth protocols

Recovery Stack

TB-500 + IGF-1 LR3 โ€” Advanced recovery combination

Potential Side Effects

TB-500 is generally well-tolerated based on anecdotal reports. Most side effects are mild and temporary, occurring primarily during the loading phase.

Common Side Effects

Rare Side Effects

โš ๏ธ Important Considerations: Due to TB-500's tissue growth properties, individuals with cancer or pre-cancerous conditions should exercise extreme caution. The peptide may theoretically promote growth of existing tumors.

Hair Growth Research

One of the most interesting areas of TB-500 research involves hair follicle development and hair growth. The peptide's parent compound, Thymosin Beta-4, plays a crucial role in hair follicle morphogenesis.

Mechanism of Action

TB-500 promotes hair growth through several mechanisms:

Anecdotal Reports

Many users report hair regrowth, particularly when combined with other hair-growth compounds. Effects are typically noticed after 8-12 weeks of consistent use. Some experience initial shedding before regrowth begins.

Hair Growth Protocol (Anecdotal)

Frequently Asked Questions

How quickly does TB-500 work?

Unlike daily peptides, TB-500 has cumulative effects. Most users report initial benefits within 2-3 weeks, with peak effects around 4-6 weeks of consistent use. The peptide's longer half-life means effects persist between injections.

Can I inject TB-500 near the injury site?

Yes, many users inject near affected areas, though systemic administration (belly fat) is equally effective due to the peptide's systemic nature. Local injection may provide psychological benefit but isn't necessary for efficacy.

Why is TB-500 dosed differently than other peptides?

TB-500 has a much longer half-life than peptides like BPC-157 or GHK-Cu. This allows for less frequent dosing (2x weekly during loading, then weekly) while maintaining effective blood levels.

Is TB-500 safe for long-term use?

Long-term safety data is limited. Most protocols involve cycling the peptide (4-8 weeks on, 2-4 weeks off) rather than continuous use. Thymosin Beta-4 is naturally produced in the body, but synthetic TB-500 concentrations exceed natural levels.

Can TB-500 be used with other peptides?

TB-500 is commonly stacked with other healing peptides like BPC-157. The "Wolverine Stack" (TB-500 + BPC-157) is particularly popular. Always research interactions and consider starting peptides separately to assess individual responses.

Why do some people experience hair shedding?

Initial hair shedding may occur as TB-500 accelerates the hair growth cycle, pushing weak hairs into the shedding phase more quickly. This is often followed by stronger regrowth, similar to what's seen with minoxidil.

๐Ÿ›’ Need Supplies?

Bacteriostatic water, syringes, and alcohol swabs for your research.

View Supplies โ†’

๐Ÿ“š References

  1. Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PubMed
  2. Philp D, Badamchian M, Scheremeta B, et al. Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. 2003;11(1):19-24. PubMed
  3. Smart N, Bollini S, Dubรฉ KN, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474(7353):640-644. PubMed
  4. Sosne G, Qiu P, Christopherson PL, Wheater MK. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp Eye Res. 2007;84(4):663-669. PubMed